{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:02:55Z","timestamp":1777536175187,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.atherosclerosis.2016.06.018","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T10:07:56Z","timestamp":1465898876000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism"],"prefix":"10.1016","volume":"251","author":[{"given":"Mario T.","family":"Kratz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan H.","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Baumh\u00e4kel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCRESAHA.116.302706","article-title":"Role of mineralocorticoid receptor antagonists in cardiovascular disease","volume":"116","author":"Ferrario","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1440-1681.12157","article-title":"Vascular effects of aldosterone: sorting out the receptors and the ligands","volume":"40","author":"Feldman","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/FJC.0b013e318258f8ce","article-title":"Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts","volume":"60","author":"Noda","year":"2012","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2215\/CJN.01340209","article-title":"Mineralocorticoid receptor blockers and chronic kidney disease","volume":"4","author":"Jain","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib6","first-page":"87","article-title":"Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-\u03b3)","volume":"62","author":"Miana","year":"2011","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib7","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1139\/y85-250","article-title":"Effect of aldosterone on vascular angiotensin II receptors in the rat","volume":"63","author":"Schiffrin","year":"1985","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib8","first-page":"205","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2007.03.024","volume":"154","author":"B\u00f6hm","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib10","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","article-title":"Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial","volume":"291","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","volume":"121","author":"B\u00f6hm","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib12","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"S1","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000158311.24443.af","article-title":"Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis","volume":"25","author":"Laufs","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators, eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"B1","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1476-5381.2011.01267.x","article-title":"Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis","volume":"163","author":"Schlimmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2010.03.002","article-title":"Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice","volume":"212","author":"Baumh\u00e4kel","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.108.140533","article-title":"Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan","volume":"327","author":"Baumh\u00e4kel","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"ONTARGET Investigators","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1388-9842(03)00112-0","article-title":"VALsartan in Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context","volume":"5","author":"Velazquez","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib27","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000158311.24443.af","article-title":"Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis","volume":"25","author":"Laufs","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.107.135681","article-title":"Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice","volume":"325","author":"Baumh\u00e4kel","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurheartj\/ehr255","article-title":"Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis","volume":"33","author":"Schirmer","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jacc.2003.07.042","article-title":"Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease","volume":"43","author":"Kaiser","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/heart.89.3.251","article-title":"Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator","volume":"89","author":"Solomon","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib35","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/hc4601.099485","article-title":"Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease","volume":"104","author":"Heitzer","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","article-title":"Sexual function in men older than 50 years of age: results from the health professionals follow-up study","volume":"139","author":"Bacon","year":"2003","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib37","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.06.018_bib38","first-page":"207","article-title":"Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study","volume":"2","author":"Speel","year":"2005","journal-title":"J.\u00a0Sex. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016302635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T21:57:15Z","timestamp":1617487035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016302635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"alternative-id":["S0021915016302635"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}